Cataract removal through the smallest possible incision
can produce universal advantages, including increased
wound sealability,
1
and a reduction in both endothelial cell
loss
2
and surgically induced astigmatism.
3
Bausch + Lomb
has redefi ned state of the art phacoemulsifi cation with its
1.8 mm MICS solution, delivering the fl uidics control and
cutting e! ciency to make the procedure through a
1.8 mm incision a reality.
Only Bausch + Lomb Delivers
The 1.8 mm MICS Platform
The Stellaris Vision Enhancement System is a key
component of the exclusive Bausch + Lomb MICS
Platform, providing Every Essential Element for
surgeons to make a successful transition to
1.8 mm micro incision cataract surgery.
Learn more about the MICS
™
Platform and the benefi ts
of 1.8 mm surgery at www.bauschsurgical.com/MICS
1. Barrett, G and Carlsson, A. Cataract Surgical Wound Strength In Vivo. COS annual meeting and exhibition, 2007, Montreal, Canada.
2. Zafi rakis, P. Microincision Cataract Surgery. Stellaris Phaco Platform Versus Infi niti Torsional Ultrasound Phaco Mode: Randomized Comparative Clinical Study.
ASCRS Symposium on Cataract, IOL and Refractive Surgery, 2009, San Francisco, CA.
3. Heg Wee Jin. Surgically Induced Astigmatism in Standard versus Micro Incision Coaxial Phacoemulsifi cation, WOC 2008, Hong Kong.
MICS
™
Phaco
Stellaris
®
Is The Key Element
©2011 Bausch & Lomb Incorporated.
TM
/
®
denote trademarks of Bausch & Lomb Incorporated. SU5555 1/10
